Tg Therapeutics earnings were $441.5M for the trailing 12 months ending Jun 30, 2026, with 651.2% growth year over year. The latest TGTX earnings report on Jun 30, 2026 announced Q2 2026 earnings of $7.8M, down 60.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TGTX reported annual earnings of $447.2M, with 1,812.4% growth. The next TGTX earnings date is Nov 2, 2026.
TGTX past earnings growth
How has TGTX's earnings growth performed historically?
What were Tg Therapeutics's earnings last quarter?
On TGTX's earnings call on Aug 3, 2026, Tg Therapeutics (NASDAQ: TGTX) reported Q2 2026 earnings per share (EPS) of $0.05, up 73.68% year over year. Total TGTX earnings for the quarter were $7.78 million. In the same quarter last year, Tg Therapeutics's earnings per share (EPS) was $0.19.
The next TGTX earnings call is Nov 2, 2026. Add TGTX to your watchlist to be reminded of Tg Therapeutics's next earnings date.
Is Tg Therapeutics profitable or losing money?
As of the last Tg Therapeutics earnings report, Tg Therapeutics is currently profitable. Tg Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $441.49 million, a 630.24% increase year over year.
What was TGTX's earnings growth in the past year?
As of Tg Therapeutics's earnings date in Aug 3, 2026, Tg Therapeutics's earnings has grown 651.22% year over year. This is 632.84 percentage points higher than the US Biotechnology industry earnings growth rate of 18.38%. TGTX earnings in the past year totalled $441.49 million.
What are Tg Therapeutics's earnings expectations?
The current EPS estimate for Tg Therapeutics's earnings report in Nov 2, 2026 is $0.36.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.